As the cost of prescription drugs continues to rise in the nation that already
pays the most in the world
for medications, federal legislators and ballot-measure committees are
proposing ways to curb those prices. But pharmaceutical companies,
worried their profit margins will decline under the pending proposals,
are spending millions of dollars against the initiatives — and in one
political bellwether state, they are employing a controversial tactic
that uses shell companies to let them evade longstanding campaign
finance disclosure laws.
No comments:
Post a Comment